Alligator Bioscience AB (publ) (STO:ATORX)
Sweden
· Delayed Price · Currency is SEK 0.196
-0.004 (-1.81%)
At close: Mar 6, 2026
Alligator Bioscience AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Operating Revenue | 0.51 | 57.77 | 58.11 | 35.7 | 12.94 | Upgrade
|
| Other Revenue | 3.91 | -0.04 | 1.14 | 0.31 | 0.38 | Upgrade
|
| Revenue | 4.42 | 57.72 | 59.25 | 36 | 13.33 | Upgrade
|
| Revenue Growth (YoY) | -92.34% | -2.58% | 64.58% | 170.14% | 141.65% | Upgrade
|
| Cost of Revenue | 77.5 | 167.21 | 218.79 | 147.73 | 86.98 | Upgrade
|
| Gross Profit | -73.07 | -109.48 | -159.54 | -111.72 | -73.66 | Upgrade
|
| Selling, General & Admin | 43.29 | 70.43 | 79.38 | 68.84 | 56.85 | Upgrade
|
| Other Operating Expenses | 1.46 | -0.12 | -0.02 | -0.03 | -0 | Upgrade
|
| Operating Expenses | 46.71 | 119.04 | 89.85 | 80.58 | 68 | Upgrade
|
| Operating Income | -119.78 | -228.52 | -249.39 | -192.3 | -141.65 | Upgrade
|
| Interest Expense | -44.27 | -19.69 | -0.48 | -0.65 | -0.23 | Upgrade
|
| Interest & Investment Income | 0.27 | 1.31 | 1.88 | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | 0.83 | -1.27 | -0.6 | -0.46 | -0.14 | Upgrade
|
| Other Non Operating Income (Expenses) | 99.4 | 14.28 | 0 | 0 | - | Upgrade
|
| EBT Excluding Unusual Items | -63.55 | -233.89 | -248.59 | -193.41 | -142.03 | Upgrade
|
| Asset Writedown | 12.2 | - | - | - | - | Upgrade
|
| Other Unusual Items | - | - | - | - | -0.96 | Upgrade
|
| Pretax Income | -51.35 | -233.89 | -248.59 | -193.4 | -141.74 | Upgrade
|
| Net Income | -51.35 | -233.89 | -248.59 | -193.4 | -141.74 | Upgrade
|
| Net Income to Common | -51.35 | -233.89 | -248.59 | -193.4 | -141.74 | Upgrade
|
| Shares Outstanding (Basic) | 28 | 1 | 0 | 0 | 0 | Upgrade
|
| Shares Outstanding (Diluted) | 28 | 1 | 0 | 0 | 0 | Upgrade
|
| Shares Change (YoY) | 3648.83% | 63.72% | 103.32% | 146.00% | 25.61% | Upgrade
|
| EPS (Basic) | -1.87 | -318.53 | -554.27 | -876.77 | -1580.64 | Upgrade
|
| EPS (Diluted) | -1.87 | -320.00 | -554.27 | -880.00 | -1580.64 | Upgrade
|
| Free Cash Flow | -157.45 | -212.43 | -191.74 | -173.05 | -127.08 | Upgrade
|
| Free Cash Flow Per Share | -5.72 | -289.30 | -427.53 | -784.49 | -1417.17 | Upgrade
|
| Gross Margin | - | -189.67% | -269.26% | - | - | Upgrade
|
| Operating Margin | -2708.14% | -395.90% | -420.90% | -534.16% | -1062.89% | Upgrade
|
| Profit Margin | -1160.98% | -405.19% | -419.55% | -537.22% | -1063.52% | Upgrade
|
| Free Cash Flow Margin | -3559.71% | -368.01% | -323.61% | -480.67% | -953.54% | Upgrade
|
| EBITDA | -117.82 | -227.58 | -248.24 | -188.89 | -136.7 | Upgrade
|
| D&A For EBITDA | 1.96 | 0.95 | 1.15 | 3.41 | 4.95 | Upgrade
|
| EBIT | -119.78 | -228.52 | -249.39 | -192.3 | -141.65 | Upgrade
|
| Revenue as Reported | 6.42 | 59.71 | 61.9 | 37.14 | 15.13 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.